Top 10 Insider Sales Last Month

6. Cencora, Inc. (NYSE:COR)

Total value of insider sales in February: $319,403,491.08

Market capitalization: $49.203 billion

Previously known under the name AmerisourceBergen Corporation, Cencora distributes pharmaceuticals in the U.S. and internationally. Based in Conshohocken, Pennsylvania, Cencora provides pharmaceuticals, over-the-counter products, home healthcare supplies, and related services to hospitals, pharmacies, clinics, and long-term care providers. Its offering includes packaging, clinical trial support, animal health products, vaccines, blood products, etc.

In February, three insiders sold a total of $319.40 million at an average price of $246.68 per share. Year-to-date, the stock rose 13.47% and is now trading at $254.94 per share. Over the past 12 months, Cencora returned 8.59% to its investors.

In the first quarter of fiscal 2025, the company had revenue of $81.5 billion, up by 12.8% from the same period of fiscal 2024. GAAP diluted earnings per share was $2.50, which compares to $2.98 in the comparable quarter of the prior year.

Ten analysts have given an average “Moderate Buy” rating on Cencora stock with a price target of $277.90, according to MarketBeat.